Does the Presence of Diabetes Mellitus Make a Difference in Pharmacological Stress Echocardiography Outcome Results?

Authors

  • Valentina Andova University Clinic of Cardiology, Faculty of Medicine, Ss Cyril and Methodius University of Skopje, Skopje, Republic of Macedonia
  • Ljubica Georgievska-Ismail University Clinic of Cardiology, Faculty of Medicine, Ss Cyril and Methodius University of Skopje, Skopje, Republic of Macedonia
  • Elizabeta Srbinovska University Clinic of Cardiology, Faculty of Medicine, Ss Cyril and Methodius University of Skopje, Skopje, Republic of Macedonia
  • Biljana Janeska Institute of Forensic Medicine, Criminalistic and Deontology, Faculty of Medicine, Ss Cyril and Methodius University of Skopje, Skopje, Republic of Macedonia

DOI:

https://doi.org/10.3889/oamjms.2018.452

Keywords:

Diabetes mellitus, Coronary artery disease, Stress echocardiography, Speckle tracking, Systolic longitudinal strain

Abstract

BACKGROUND: Coronary artery disease (CAD) is the leading cause of mortality and morbidity in patients with diabetes (DM).

AIM: Тhe aim of our study was to analyse the ability of pharmacological SE to risk stratify patients with DM using qualitative and quantitative assessment of LV function.

METHODS: We prospectively assessed 105 consecutive patients (58.7 ± 9.5 y, 39 male) with known or suspected CAD who underwent dipyridamole or dobutamine SE.

RESULTS: Change of systolic LV function at maximal SE was less pronounced in patients with DM, while parameters of the diastolic function and its change with stress were almost insignificant. WMSI in comparison to GLS% didn’t make a difference in SE outcome regarding DM presence. WMSI was almost unchanged at maximal stress in diabetic patients. Conversely, GLS% showed significant worsening at maximal stress in diabetic patients. However, only WMSI at maximal stress along with DM presence appeared as independent predictors of the presence of new and worsening CAD during SE. Longitudinal strain assessed using speckle tracking during pharmacological stress echocardiography was superior to conventional echocardiography expressed by wall motion analysis in making a difference regarding DM presence.

CONCLUSION: We confirmed the usefulness of stress echocardiography using qualitative and/or quantitative parameters in the detection of CAD in patients with DM.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: the Framingham study. Circulation. 1979; 59(1):8-13. https://doi.org/10.1161/01.CIR.59.1.8

Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10-11 February 1998, Miami, Florida. American Diabetes Association. Diabetes Care. 1998; 21(9):1551-9. https://doi.org/10.2337/diacare.21.9.1551 PMid:9727908

The BARI Investigators. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease. Circulation. 1997; 96(6):1761-9. https://doi.org/10.1161/01.CIR.96.6.1761

Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic dubjects with and without prior myocardial infarction. N Engl J Med. 1998; 339(4):229-34. https://doi.org/10.1056/NEJM199807233390404 PMid:9673301

The sixth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure national institutes of health national heart, lung, and blood institute national high blood pressure education program. http://www.sld.cu/galerias/pdf/servicios/hta/6to._reporte_del_jnc_usa.pdf

Collins R et al. MRC/BHF Heart protection study of cholesterol lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controled trial. Lancet. 2003; 361:1005-16

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet trialists' Collaboration. BMJ. 1994; 308(6921):81-106. https://doi.org/10.1136/bmj.308.6921.81 PMid:8298418 PMCid:PMC2539220

Supplement 1. American Diabetes Association: clinical practice recommendations 2000. Diabetes Care. 2000; 23(Suppl 1):S1-116. PMid:10859117

Detre KM, Guo P, Holubkov R, et al. Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Bypass Angioplasty Revascularization Investigation (BARI). Circulation. 1999; 99(5):633-40. https://doi.org/10.1161/01.CIR.99.5.633 PMid:9950660

Cameron M et al. Diabetes and periferal vascular disease. J Vasc Surg. 1999; 30(2);373-84. https://doi.org/10.1016/S0741-5214(99)70154-0

May O, Arildsen H, Damsgaard EM, Mickley H. Cardiovascular autonomic neuropathy in insulin-dependent diabetes mellitus: prevalence and estimated risk of coronary heart disease in the general population. J Intern Med. 2000; 248(6):483-91. https://doi.org/10.1046/j.1365-2796.2000.00756.x PMid:11155141

Koistinen MJ. Prevalence of asymptomatic myocardial ischaemia in diabetic subjects. BMJ. 1990; 301(6743):92-5. https://doi.org/10.1136/bmj.301.6743.92 PMid:2390590 PMCid:PMC1663397

Tarnow L, Rossing P, Gall MA, Nielsen FS, Parving HH. Prevalence of arterial hypertension in diabetic patients before and after the JNC-V. Diabetes Care. 1994; 17(11):1247-51. https://doi.org/10.2337/diacare.17.11.1247 PMid:7821162

Nahser PJ, Brown RE, Oskarsson H, Winniford MD, Rossen JD. Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation. 1995; 91(3):635-40. https://doi.org/10.1161/01.CIR.91.3.635 PMid:7828287

Elhendy A, van Domburg RT, Poldermans D, et al. Safety and feasibility of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in diabetic patients unable to perform an exercise stress test. Diabetes Care. 1998; 21(11):1797-802. https://doi.org/10.2337/diacare.21.11.1797 PMid:9802723

Bigi R, Desideri A, Cortigiani L, Bax JJ, Celegon L, Fiorentini C. Stress echocardiography for risk stratification of diabetic patients with known or suspected coronary artery disease. Diabetes Care. 2001; 24(9):1596-601. https://doi.org/10.2337/diacare.24.9.1596 PMid:11522705

Elhendy A, Arruda AM, Mahoney DW, Pellikka PA. Prognostic stratification of diabetic patients by exercise echocardiography. J Am Coll Cardiol. 2001; 37(6):1551-7. https://doi.org/10.1016/S0735-1097(01)01199-8

Marwick TH, Case C, Sawada S, Vasey C, Short L, Lauer M. Use of stress echocardiography to predict mortality in patients with diabetes and known or suspected coronary artery disease. Diabetes Care. 2002; 25(6):1042-8. https://doi.org/10.2337/diacare.25.6.1042 PMid:12032112

Sozzi FB, Elhendy A, Roelandt JRTC, et al. Prognostic value of dobutamine stress echocardiography in patients with diabetes. Diabetes Care. 2003; 26(4):1074-8. https://doi.org/10.2337/diacare.26.4.1074 PMid:12663576

Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015; 16:233-71. https://doi.org/10.1093/ehjci/jev014 PMid:25712077

Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016; 29:277-314. https://doi.org/10.1016/j.echo.2016.01.011 PMid:27037982

Pellikka PA, Nagueh SF, Elhendy AA, Kuehl CA, Sawada SG, American Society of Echocardiography. American Society of Echocardiography Recommendations for performance, interpretation, and application of stress echocardiography. J Am Soc Echocardiogr. 2007; 20(9):1021-41. https://doi.org/10.1016/j.echo.2007.07.003 PMid:17765820

Sicari R, Nihoyannopoulos P, Evangelista A, et al. Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr. 2008; 9(4):415-37. https://doi.org/10.1093/ejechocard/jen175 PMid:18579481

Mor-Avi V, Lang RM, Badano LP, et al. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE Consensus statement on methodology and indications. J Am Soc Echocardiogr. 2011; 24(3):277-313. https://doi.org/10.1016/j.echo.2011.01.015 PMid:21338865

Yingchoncharoen T, Agarwal S, Popović ZB, Marwick TH. Normal ranges of left ventricular strain: A meta-analysis. J Am Soc Echocardiogr. 2013; 26(2):185-91. https://doi.org/10.1016/j.echo.2012.10.008 PMid:23218891

Sugimoto T, Dulgheru R, Bernard A, et al. Echocardiographic reference ranges for normal left ventricular 2D strain: results from the EACVI NORRE study. Eur Hear J - Cardiovasc Imaging. 2017; 18(8):833-40. https://doi.org/10.1093/ehjci/jex140 PMid:28637227

Burgess MI, Jenkins C, Sharman JE, Marwick TH. Diastolic stress echocardiography: hemodynamic validation and clinical significance of estimation of ventricular filling pressure with exercise. J Am Coll Cardiol. 2006; 47(9):1891-900. https://doi.org/10.1016/j.jacc.2006.02.042 PMid:16682317

Hyodo E, Hirata K, Hirose M, et al. Clinical use of doppler echocardiography and doppler tissue imaging in the estimation of myocardial ischemia during dobutamine stress echocardiography. J Am Soc Echocardiogr. 2008; 21(4):331-6. https://doi.org/10.1016/j.echo.2007.09.005 PMid:18029141

Joyce E, Delgado V, Bax JJ, Marsan NA. Advanced techniques in dobutamine stress echocardiography: focus on myocardial deformation analysis. Heart. 2015; 101:72-81. https://doi.org/10.1136/heartjnl-2013-303850 PMid:24760702

Agarwal R, Gosain P, Kirkpatrick JN, et al. Tissue doppler imaging for diagnosis of coronary artery disease: a systematic review and meta-analysis. Cardiovasc Ultrasound. 2012; 10(1):47. https://doi.org/10.1186/1476-7120-10-47 PMid:23199010 PMCid:PMC3542063

Hoffmann S, Jensen JS, Iversen AZ, et al. Tissue Doppler echocardiography improves the diagnosis of coronary artery stenosis in stable angina pectoris. Eur Hear J - Cardiovasc Imaging. 2012; 13(9):724-9. https://doi.org/10.1093/ehjci/jes001 PMid:22323549

Ha J-W,Lee H-C,Kang E-S, et al.Abnormal left ventricular longitudinal functional reserve in patients with diabetes mellitus:implication for detecting subclinical myocardial dysfunction using exercise tissue Doppler echocardiography. Heart. 2006; 93(12):1571-6. https://doi.org/10.1136/hrt.2006.101667 PMid:17449503 PMCid:PMC2095774

Cortigiani L, Bigi R, Sicari R, Landi P, Bovenzi F, Picano E. Prognostic value of pharmacological stress echocardiography in diabetic and nondiabetic patients with known or suspected coronary artery disease. J Am Coll Cardiol. 2006; 47(3):605-10. https://doi.org/10.1016/j.jacc.2005.09.035 PMid:16458144

Budoff MJ, Raggi P, Beller GA, et al. Noninvasive cardiovascular risk assessment of the asymptomatic diabetic patient: The imaging council of the American College of Cardiology. JACC Cardiovasc Imaging. 2016; 9(2):176-92. https://doi.org/10.1016/j.jcmg.2015.11.011 PMid:26846937 PMCid:PMC5371352

Picano E. Diabetic cardiomyopathy. the importance of being earliest. J Am Coll Cardiol. 2003; 42(3):454-7. https://doi.org/10.1016/S0735-1097(03)00647-8

You Fang Z, Najos-Valencia O, Leano R, Marwick TH, Brisbane F. Echo assessment of diabetes and mitral regurgitation patients with early diabetic heart disease demonstrate a normal myocardial response to dobutamine. J Am Coll Cardiol. 2003; 42:446-53. https://doi.org/10.1016/S0735-1097(03)00654-5

Voigt JU, Exner B, Schmiedehausen K, et al. Strain-rate imaging during dobutamine stress echocardiography provides objective evidence of inducible ischemia. Circulation. 2003; 107(16):2120-26. https://doi.org/10.1161/01.CIR.0000065249.69988.AA PMid:12682001

Ng ACT, Sitges M, Pham PN, et al. Incremental value of 2-dimensional speckle tracking strain imaging to wall motion analysis for detection of coronary artery disease in patients undergoing dobutamine stress echocardiography. Am Heart J. 2009; 158(5):836-44. https://doi.org/10.1016/j.ahj.2009.09.010 PMid:19853706

Uusitalo V, Luotolahti M, Pietilä M, et al. Two-dimensional speckle-tracking during dobutamine stress echocardiography in the detection of myocardial ischemia in patients with suspected coronary artery disease. J Am Soc Echocardiogr. 2016; 29(5):470-9. https://doi.org/10.1016/j.echo.2015.12.013 PMid:26852941

Bjork Ingul C, Stoylen A, Slordahl SA, Wiseth R, Burgess M, Marwick TH. Automated analysis of myocardial deformation at dobutamine stress echocardiography. J Am Coll Cardiol. 2007; 49(15):1651-9. https://doi.org/10.1016/j.jacc.2007.01.059 PMid:17433958

Rumbinaitė E, Žaliaduonytė-Pekšienė D, Vieželis M, et al. Dobutamine-stress echocardiography speckle-tracking imaging in the assessment of hemodynamic significance of coronary artery stenosis in patients with moderate and high probability of coronary artery disease. Medicina (B Aires). 2016; 52(6):331-9. https://doi.org/10.1016/j.medici.2016.11.005 PMid:27932192

Aggeli C, Lagoudakou S, Felekos I, et al. Two-dimensional speckle tracking for the assessment of coronary artery disease during dobutamine stress echo: clinical tool or merely research method. Cardiovasc Ultrasound. 2015; 13:43. https://doi.org/10.1186/s12947-015-0038-z PMid:26498476 PMCid:PMC4619392

Celutkiene J, Zakarkaite D, Skorniakov V, et al. Quantitative approach using multiple single parameters versus visual assessment in dobutamine stress echocardiography. Cardiovascular ultrasound. 2012; 10:31. https://doi.org/10.1186/1476-7120-10-31 PMid:22846395 PMCid:PMC3495225

Nagy AI, Sahlen A, Manouras A, et al. Combination of contrast-enhanced wall motion analysis and myocardial deformation imaging during dobutamine stress echocardiography. Eur Hear J - Cardiovasc Imaging. 2015; 16(1):88-95. https://doi.org/10.1093/ehjci/jeu171 PMid:25187604

Elhendy A, Arruda AM, Mahoney DW, et al. Prognostic stratification of diabetic patients by exercise echocardiography. J Am Coll Cardiol. 2001; 35:1551-7. https://doi.org/10.1016/S0735-1097(01)01199-8

Chaowalit N, Arruda AL, McCully RB, Bailey KR, Pellikka PA. Dobutamine stress echocardiography in patients with diabetes mellitus. J Am Coll Cardiol. 2006; 47(5):1029-36. https://doi.org/10.1016/j.jacc.2005.10.048 PMid:16516089

Wierzbowska-Drabik K, Trzos E, Kurpesa M, et al. Diabetes as an independent predictor of left ventricular longitudinal strain reduction at rest and during dobutamine stress test in patients with significant coronary artery disease. Eur Hear J - Cardiovasc Imaging. 2017; 0:1-11.

Philouze C, Obert P, Nottin S, Benamor A, Barthez O, Aboukhoudir F. Dobutamine stress echocardiography unmasks early left ventricular dysfunction in asymptomatic patients with uncomplicated type 2 diabetes: A comprehensive two-dimensional speckle-tracking imaging study. J Am Soc Echocardiogr. 2018; 31(5):587-97. https://doi.org/10.1016/j.echo.2017.12.006 PMid:29526563

Published

2018-11-20

How to Cite

1.
Andova V, Georgievska-Ismail L, Srbinovska E, Janeska B. Does the Presence of Diabetes Mellitus Make a Difference in Pharmacological Stress Echocardiography Outcome Results?. Open Access Maced J Med Sci [Internet]. 2018 Nov. 20 [cited 2024 Apr. 18];6(11):2084-90. Available from: https://oamjms.eu/index.php/mjms/article/view/oamjms.2018.452

Issue

Section

B - Clinical Sciences

Most read articles by the same author(s)